Swathi Ramakrishnan

1.3k total citations
28 papers, 902 citations indexed

About

Swathi Ramakrishnan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Swathi Ramakrishnan has authored 28 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Swathi Ramakrishnan's work include Epigenetics and DNA Methylation (13 papers), Histone Deacetylase Inhibitors Research (7 papers) and Prostate Cancer Treatment and Research (7 papers). Swathi Ramakrishnan is often cited by papers focused on Epigenetics and DNA Methylation (13 papers), Histone Deacetylase Inhibitors Research (7 papers) and Prostate Cancer Treatment and Research (7 papers). Swathi Ramakrishnan collaborates with scholars based in United States, Italy and Argentina. Swathi Ramakrishnan's co-authors include Роберто Пили, Leigh Ellis, Kiersten Marie Miles, Li Shen, Sheng‐Yu Ku, Eric Ciamporcero, Paula Sotomayor, Robert A. Fenstermaker, Michael J. Ciesielski and Remi Adelaiye‐Ogala and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Swathi Ramakrishnan

27 papers receiving 894 citations

Peers

Swathi Ramakrishnan
Kiersten Marie Miles United States
Ling Huw United States
Ashley Orillion United States
Mengqian Chen United States
Trista K. Hinz United States
Antreas Hindoyan United States
David Molkentine United States
Edward J. Hartsough United States
Kiersten Marie Miles United States
Swathi Ramakrishnan
Citations per year, relative to Swathi Ramakrishnan Swathi Ramakrishnan (= 1×) peers Kiersten Marie Miles

Countries citing papers authored by Swathi Ramakrishnan

Since Specialization
Citations

This map shows the geographic impact of Swathi Ramakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swathi Ramakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swathi Ramakrishnan more than expected).

Fields of papers citing papers by Swathi Ramakrishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swathi Ramakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swathi Ramakrishnan. The network helps show where Swathi Ramakrishnan may publish in the future.

Co-authorship network of co-authors of Swathi Ramakrishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Swathi Ramakrishnan. A scholar is included among the top collaborators of Swathi Ramakrishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swathi Ramakrishnan. Swathi Ramakrishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dupuis, L. Lee, Brian T. Fisher, Swathi Ramakrishnan, et al.. (2024). Clinical practice guideline‐inconsistent management of fever and neutropenia in pediatric oncology: A Children's Oncology Group study. Pediatric Blood & Cancer. 71(4). e30880–e30880. 1 indexed citations
2.
Ramakrishnan, Swathi, Kristopher Attwood, Spencer R. Rosario, et al.. (2024). Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer. Genome Medicine. 16(1). 52–52. 3 indexed citations
3.
Ramakrishnan, Swathi, Rick A. Kittles, Wendy J. Huss, et al.. (2023). Serum Androgen Metabolites Correlate with Clinical Variables in African and European American Men with Localized, Therapy Naïve Prostate Cancer. Metabolites. 13(2). 284–284. 2 indexed citations
4.
Krishnan, Nithya, Swathi Ramakrishnan, Eduardo Cortes Gomez, et al.. (2022). STAG2 Expression is Associated with Adverse Survival Outcomes and Regulates Cell Phenotype in Muscle-invasive Bladder Cancer. Cancer Research Communications. 2(10). 1129–1143. 7 indexed citations
5.
Elbanna, May, Ashley Orillion, Nur P. Damayanti, et al.. (2019). Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell Carcinoma. Molecular Cancer Therapeutics. 19(1). 147–156. 10 indexed citations
6.
Ramakrishnan, Swathi, Monika Rak, Qiang Hu, et al.. (2019). Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer. Cell Death and Differentiation. 26(10). 2100–2114. 74 indexed citations
7.
Ramakrishnan, Swathi, Susan E. Steck, Lenore Arab, et al.. (2019). Association among plasma 1,25(OH)2D, ratio of 1,25(OH)2D to 25(OH)D, and prostate cancer aggressiveness. The Prostate. 79(10). 1117–1124. 17 indexed citations
8.
Ramakrishnan, Swathi, Qiang Hu, Nithya Krishnan, et al.. (2017). Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer. Cell Death and Disease. 8(12). 3217–3217. 27 indexed citations
9.
Ramakrishnan, Swathi, Sheng‐Yu Ku, Eric Ciamporcero, et al.. (2016). HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma. BMC Cancer. 16(1). 617–617. 35 indexed citations
10.
Ciamporcero, Eric, He Shen, Swathi Ramakrishnan, et al.. (2015). YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage. Oncogene. 35(12). 1541–1553. 108 indexed citations
11.
Adelaiye‐Ogala, Remi, Eric Ciamporcero, Kiersten Marie Miles, et al.. (2014). Sunitinib Dose Escalation Overcomes Transient Resistance in Clear Cell Renal Cell Carcinoma and Is Associated with Epigenetic Modifications. Molecular Cancer Therapeutics. 14(2). 513–522. 56 indexed citations
12.
Shen, Li, Anette Sundstedt, Michael J. Ciesielski, et al.. (2014). Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models. Cancer Immunology Research. 3(2). 136–148. 74 indexed citations
13.
Ku, Sheng‐Yu, Elena Lasorsa, Remi Adelaiye‐Ogala, et al.. (2014). Inhibition of Hsp90 Augments Docetaxel Therapy in Castrate Resistant Prostate Cancer. PLoS ONE. 9(7). e103680–e103680. 11 indexed citations
14.
Ciamporcero, Eric, Kiersten Marie Miles, Remi Adelaiye‐Ogala, et al.. (2014). Combination Strategy Targeting VEGF and HGF/c-met in Human Renal Cell Carcinoma Models. Molecular Cancer Therapeutics. 14(1). 101–110. 77 indexed citations
15.
Ramakrishnan, Swathi, Sheng‐Yu Ku, Wendy M. Swetzig, et al.. (2014). Abstract 4061: Evidence for hdac6 and er-α association in a subset of clear cell renal cell carcinoma. Cancer Research. 74(19_Supplement). 4061–4061. 1 indexed citations
16.
Ramakrishnan, Swathi & Роберто Пили. (2013). Histone Deacetylase Inhibitors and Epigenetic Modifications as a Novel Strategy in Renal Cell Carcinoma. The Cancer Journal. 19(4). 333–340. 24 indexed citations
17.
Ellis, Leigh, Sheng‐Yu Ku, Swathi Ramakrishnan, et al.. (2013). Combinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate cancer. Oncotarget. 4(12). 2225–2236. 57 indexed citations
18.
Shen, Li, Michael J. Ciesielski, Swathi Ramakrishnan, et al.. (2012). Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models. PLoS ONE. 7(1). e30815–e30815. 167 indexed citations
19.
Ellis, Leigh, et al.. (2011). Development of a castrate resistant transplant tumor model of prostate cancer. The Prostate. 72(6). 587–591. 17 indexed citations
20.
Ellis, Leigh, Swathi Ramakrishnan, Remi Adelaiye‐Ogala, et al.. (2011). Concurrent HDAC and mTORC1 Inhibition Attenuate Androgen Receptor and Hypoxia Signaling Associated with Alterations in MicroRNA Expression. PLoS ONE. 6(11). e27178–e27178. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026